Carnegie Lake Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Carnegie Lake Advisors's LLY Position: Q3 2026 in Review
Carnegie Lake Advisors increased its Eli Lilly (LLY) stake by 5.1% in Q3 2026, buying an estimated $22.4K and bringing the position to 390 shares worth $451K. The position accounts for 0.17% of the portfolio, ranked #116.
Carnegie Lake Advisors first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. 4,065 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Carnegie Lake Advisors held 390 shares of Eli Lilly worth $451K as of Q3 2026.
- Carnegie Lake Advisors bought 19 Eli Lilly shares in Q3 2026, an estimated $22.4K.
- Eli Lilly made up 0.17% of Carnegie Lake Advisors's portfolio in Q3 2026, its #116 holding.
- Carnegie Lake Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
- 4,065 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Carnegie Lake Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.